Search for: "Price v. District of Columbia"
Results 381 - 400
of 500
Sorted by Relevance
|
Sort by Date
13 Mar 2017, 10:00 am
The 31 states and the District of Columbia that expanded their Medicaid programs would continue to receive enhanced federal funding until 2020. [read post]
25 Jun 2015, 9:01 am
After all, the ACA specifically defines “State” as “each of the 50 States and the District of Columbia. [read post]
27 Nov 2019, 5:45 am
In light of states’ differing responses to the Wayfair v. [read post]
13 Aug 2014, 3:00 pm
” Between mid-2011 and 2014, the CFPB said, Amerisave advertised its interest rates and terms in all 50 states and the District of Columbia using banner ads and rate tables on third-party websites. [read post]
14 Aug 2014, 2:01 pm
” Between mid-2011 and 2014, the CFPB said, Amerisave advertised its interest rates and terms in all 50 states and the District of Columbia using banner ads and rate tables on third-party websites. [read post]
5 Jun 2019, 9:58 am
The district court dismissed the case. [read post]
3 Apr 2017, 6:34 pm
This article explains why the price of repeating arms declined so steeply. [read post]
27 Jun 2011, 10:11 am
Answer: No The Court of Appeals for the District of Columbia Circuit ruled it could, a decision the justices reversed. [read post]
14 Dec 2017, 10:48 pm
American Indian Trust $3.4 billion In 2011, a federal judge in the District of Columbia granted final approval for a $3.4 billion settlement over American Indian claims that the federal government had mismanaged funds in land trust accounts dating back to the 19th century. [read post]
11 Apr 2024, 9:48 pm
Supreme Court decision in West Virginia v. [read post]
7 Nov 2016, 3:06 pm
District of Columbia judge Roy Pearson filed suit against Custom Cleaners, a neighborhood dry-cleaning business run by the Chung family, over a pair of misplaced pants. [read post]
17 Jun 2021, 7:30 am
But why not include Chisholm v. [read post]
10 Jul 2013, 1:32 pm
Columbia Records v. [read post]
9 Apr 2022, 3:01 am
Doe v. [read post]
17 Nov 2011, 10:00 am
Court of Appeals for the District of Columbia Circuit added to the suspense surrounding the litigation when it too upheld the constitutionality of the individual mandate. [read post]
8 Jul 2014, 4:20 am
In American Pipe & Construction Co. v. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property Watch),… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
